Home/Investors/CBC Group

CBC Group

Biotech Investor · 11 portfolio companies

Portfolio

11

Focus Areas

10

Top Stage

phase-1

Investment Focus

Oncology Immunology Muscular Dystrophy Neuromuscular Diseases Genetics & Genomics Metabolic Neuroscience Antibodies Ophthalmology Rare Disease

Portfolio Companies

Company	Stage	Valuation	Focus
CytoCares	preclinical	—	Oncology
3D Medicines	commercial	—	Oncology, Immunology
MLAB Biosciences	Pre-clinical	—	Muscular Dystrophy, Neuromuscular Diseases
Ractigen Therapeutics	preclinical	—	Genetics & Genomics, Oncology
Immunotech Biopharm	phase-1	—	Oncology, Immunology
Pegbio	phase-3	—	Metabolic
Joinstar Biomedical Technology	phase-1	—	Oncology
Doer Biologics	phase-1	—	Oncology, Immunology
Lupeng Pharmaceutical	phase-2	—	Neuroscience
C-Ray Therapeutics	phase-1	—	Oncology, Antibodies
AffaMed Therapeutics	phase-3	—	Ophthalmology, Neuroscience

Frequent Co-Investors

OrbiMed Asia4 shared TF Capital3 shared Lilly Asia Ventures2 shared Loyal Valley Capital2 shared Hillhouse Capital1 shared Qiming Venture Partners1 shared LYFE Capital1 shared Sinopharm Capital1 shared